ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 655

Non-White Race, Younger Age, and Use of Primary and Gynecologic Care Are Associated with Higher Rates of Cervical Cancer Screening in Systemic Lupus Erythematosus Patients At a Public Hospital

Jennifer Stichman1, Angela Keniston2, Joann Zell3, Jinoos Yazdany4, Itziar Quinzanos1 and Joel M. Hirsh5, 1Dept Medicine, Denver Health Med Ctr, Denver, CO, 2Department of Medicine, Denver Health and Hospital Authority, Denver, CO, 3Medicine, National Jewish Health, Denver, CO, 4Medicine, University of California, San Francisco, San Francisco, CA, 5Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: health disparities, prevention, quality of care, systemic lupus erythematosus (SLE) and women's health

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at increased risk of cervical dysplasia and persistent Human Papilloma Virus (HPV) infection. There are few prior studies looking at cervical cancer screening in SLE, and these have relied upon self-report to document if screening was done appropriately. These studies have also not included uninsured and non-English speaking subjects. We examined performance of cervical cancer screening in patients with SLE at Denver Health (DH) as well as sociodemographic and other predictors of screening.

Methods: Using data from the DH electronic health record (EHR), we identified rheumatology clinic patients with initial encounters between July 2006 and August 2011 who had SLE, were female, and were between the ages of 21-50 years. We queried data from the EHR including age, race/ethnicity, primary language, use of interpreter services and primary payer. We also queried the EHR regarding the rates of cervical cancer screening in this cohort and at DH overall. Manual record review was conducted to review medication use and possible history of hysterectomy. A chi-square test was used to test differences in the proportion of SLE patients with cervical cancer screening documented within one year pre or post index encounter and within three years pre or post index encounter by patient demographics. We looked at screening rates at both 1 and 3 year intervals depending on age, as 2003 American College of Obstetrics and Gynecology guidelines had  recommended annual screening in women younger than 30. 

Results: One hundred twenty eight patients with SLE were identified. Six of these patients were status post hysterectomy unrelated to cervical cancer. Data was analyzed for the remaining 122 patients. Eighty percent were non-White and half did not have health insurance. Overall, rates of cervical cancer screening within 3 years were 75% in DH primary care clinics and 66% in SLE patients. In our SLE cohort, only 60% of women age 30-50 underwent cervical cancer screening in 3 years, in contrast to 81% of patients age 21-29 (p = 0.0235). In unadjusted analyses, White women were less likely to have screening in 3 years compared to non-White women in the 21-29 age group  (p=0.0147). Women in the 21-29 age group with a history of gynecologic care were had a higher likelihood of screening at 3 years (p=0.0378). In the 30-50 age group, having seen a primary care physician was associated with a higher likelihood of screening at 1 and 3 years (p=0.0013 and 0.0040 respectively) and history of gynecology care was associated with increased likelihood of having a screening test at 1 and 3 years (p=0.0013 and 0.0003 respectively). Patients receiving immunosuppressive medications were no more likely to receive cervical cancer screening than other SLE patients.

Conclusion: We identified a gap in care in large subsets of the SLE patients at DH. White women age 21-29 and patients age 30-50 were less likely than the general primary care DH population to have appropriate cervical cancer screening. Rheumatologists need to help connect female SLE patients of all races and ethnicities with primary or gynecology care services as patients who limit physician visits to rheumatology are at risk of not being screened for cervical cancer.


Disclosure:

J. Stichman,
None;

A. Keniston,
None;

J. Zell,
None;

J. Yazdany,
None;

I. Quinzanos,
None;

J. M. Hirsh,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-white-race-younger-age-and-use-of-primary-and-gynecologic-care-are-associated-with-higher-rates-of-cervical-cancer-screening-in-systemic-lupus-erythematosus-patients-at-a-public-hospital/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology